From top leadership to “the humble vaccinator”

Independent Monitoring Board publishes its February 2012 report

20120217_IMB
A group of Nigerian women (one holding a megaphone) advocating polio vaccination WHO/T. Moran

In the report of its January 2012 meeting, the Independent Monitoring Board (IMB) congratulates the Indian government and its partners on that country’s monumental milestone, and recognizes the work of the GPEI since the October 2011 IMB report, in response to the January 2012 Executive Board (EB) Resolution, to elevate the polio eradication effort on an emergency footing for 2012-2013.

At the same time, however, the IMB expresses alarm that this emergency must still lead to a transformation in approach at the front-line – the motivation of “the humble vaccinator” — to improve programme quality and accountability. In particular, the IMB is extremely concerned at the increase in polio transmission in Nigeria and Pakistan, stating that together, these two countries now constitute the most potent threat to the possibility of global eradication.

With the experience in India clearly demonstrating the feasibility of success, the IMB underscores that the opportunity to finish this disease once and for all must not be lost. Failure, it warns, would “unleash the virus, paralysing hundreds of thousands of children.” To this effect, the IMB puts forward key recommendations to both countries and GPEI partners, to build on its previous recommendations. Over the coming weeks, the GPEI partners will conduct vast consultations with partners at all levels and governments counterparts – in particular in Nigeria and Pakistan – to discuss concrete ways to ensure the emergency is fully addressed at all levels.


Related News

   14/09/2021
Update on polio eradication efforts in Pakistan for August 2021
   14/09/2021
GPEI joins the 5-year action journey to achieve irreversible progress towards gender equality
   27/08/2021
Three polio survivors from Mozambique, Congo and Ethiopia share their experiences of living with the effects of disease, and their hope for a polio-free world.
   27/08/2021
Learn how the type 2 novel oral polio vaccine (nOPV2) is being rolled out across Africa to help more sustainably address outbreaks of a non-wild form of polio, cVDPV2, and protect children across the continent.
   27/08/2021
Despite success against wild polio in the African region, outbreaks of the non-wild form of polio, cVDPV2, continue. With continued country commitment to eradication, a future where no child in Africa is paralysed by the virus is possible.